|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 259/06 | |
| C07C 309/66 | |||
| C07C 317/22 | |||
| C07D 213/30 | |||
| C07D 213/68 | |||
| A61K 31/44 | |||
| A61K 31/16 | |||
| A61K 31/10 | |||
| A61P 3/00 |
| (11) | Number of the document | 3024816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14750080.5 |
| Date of filing the European patent application | 2014-07-21 | |
| (97) | Date of publication of the European application | 2016-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/047411 |
| Date | 2014-07-21 |
| (87) | Number | WO 2015/013187 |
| Date | 2015-01-29 |
| (30) | Number | Date | Country code |
| 201361856850 P | 2013-07-22 | US |
| (72) |
TANIS, Steven P., US
LARSEN, Scott D., US
ARTMAN, Gerald D., III, US
PARKER, Timothy, US
|
| (73) |
Metabolic Solutions Development Company, LLC,
161 East Michigan Avenue, 4th Floor, Kalamazoo, MI 49007,
US
|
| (54) | PPAR-SPARING COMPOUNDS FOR THE TREATMENT OF METABOLIC DISEASES |
| PPAR-SPARING COMPOUNDS FOR THE TREATMENT OF METABOLIC DISEASES |